IDEAYA Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-115.2M | $-117.6M | $2.4M | $18.5M |
| FY2024 | $-247.6M | $-251.4M | $3.9M | $34.7M |
| FY2025 | $-71.1M | $-73.5M | $2.4M | $46.1M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-115.2M | $-117.6M | $2.4M | $18.5M |
| FY2024 | $-247.6M | $-251.4M | $3.9M | $34.7M |
| FY2025 | $-71.1M | $-73.5M | $2.4M | $46.1M |